Insider Trading Activity Pieris Pharmaceuticals Inc (NASDAQ:PIRS) – Director Bought 10,000 shares of Stock

Insider Trading Activity For Pieris Pharmaceuticals Inc (NASDAQ:PIRS)

James A Geraghty , Director of Pieris Pharmaceuticals Inc (NASDAQ:PIRS) reportedly Bought 10,000 shares of the company’s stock at an average price of 5.75 for a total transaction amount of $57,500.00 SEC Form

Insider Trading History For Pieris Pharmaceuticals Inc (NASDAQ:PIRS)

  • On 6/13/2016 Stephen S Yoder, CEO, bought 6,000 with an average share price of $1.68 per share and the total transaction amounting to $10,080.00.
  • On 6/13/2016 Darlene M Deptula-Hicks, CFO, bought 5,000 with an average share price of $1.66 per share and the total transaction amounting to $8,300.00.
  • On 6/14/2016 Louis Matis, SVP, bought 10,000 with an average share price of $1.70 per share and the total transaction amounting to $17,000.00.
  • On 8/17/2017 James A Geraghty, Director, bought 10,000 with an average share price of $4.82 per share and the total transaction amounting to $48,200.00.
  • On 8/17/2017 Allan Reine, Insider, bought 65,000 with an average share price of $4.82 per share and the total transaction amounting to $313,300.00.
  • On 12/18/2017 Orbimed Advisors Llc, Major Shareholder, sold 147,635 with an average share price of $5.70 per share and the total transaction amounting to $841,519.50.
  • On 1/3/2018 Orbimed Advisors Llc, Major Shareholder, sold 1,709,620 with an average share price of $7.35 per share and the total transaction amounting to $12,565,707.00.
  • Analyst Ratings History For Pieris Pharmaceuticals Inc (NASDAQ:PIRS)

    • On 9/28/2016 Roth Capital Reiterated Rating Buy with a price target of $6.00
    • On 4/12/2017 Oppenheimer Set Price Target of rating Buy with a price target of $9.00
    • On 5/30/2017 Rodman & Renshaw Initiated Coverage of rating Buy ➝ Buy with a price target of $9.00
    • On 1/17/2018 William Blair Initiated Coverage of rating Outperform
    • On 3/19/2018 Jefferies Group Initiated Coverage of rating Buy ➝ Buy with a price target of $12.00
    • On 3/19/2018 Evercore ISI Initiated Coverage of rating Outperform ➝ Outperform with a price target of $13.00
    • On 5/4/2018 Cowen Initiated Coverage of rating Outperform

    Recent Trading Activity for Pieris Pharmaceuticals Inc (NASDAQ:PIRS)
    Shares of Pieris Pharmaceuticals Inc closed the previous trading session at 5.92 up +0.17 2.87% with 5.820000171661377 shares trading hands.

    An ad to help with our costs